IMAGO BIOSCIENCES Trademark

Trademark Overview

On Monday, November 24, 2014, a trademark application was filed for IMAGO BIOSCIENCES with the United States Patent and Trademark Office. The USPTO has given the IMAGO BIOSCIENCES trademark a serial number of 86977722. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Monday, May 16, 2022. This trademark is owned by IMAGO BIOSCIENCES, INC.. The IMAGO BIOSCIENCES trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development
imago biosciences

General Information

Serial Number86977722
Word MarkIMAGO BIOSCIENCES
Filing DateMonday, November 24, 2014
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateMonday, May 16, 2022
Registration Number4876093
Registration DateTuesday, December 22, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 5, 2015

Trademark Statements

Pseudo MarkIMAGO BIO SCIENCES
NOT AVAILABLE"BIOSCIENCES"
Goods and ServicesPharmaceutical research and development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, December 2, 2014
Primary Code042
First Use Anywhere DateWednesday, March 28, 2012
First Use In Commerce DateTuesday, October 23, 2012

Trademark Owner History

Party NameIMAGO BIOSCIENCES, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSAN CARLOS, CA 940704323
Party NameIMAGO BIOSCIENCES, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSAN CARLOS, CA 940704323
Party NameIMAGO BIOSCIENCES, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSAN CARLOS, CA 940704323

Trademark Events

Event DateEvent Description
Friday, March 13, 2015ASSIGNED TO EXAMINER
Thursday, November 27, 2014NEW APPLICATION ENTERED
Tuesday, December 2, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, December 3, 2014NOTICE OF PSEUDO MARK E-MAILED
Saturday, March 14, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 15, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 5, 2015PUBLISHED FOR OPPOSITION
Tuesday, May 5, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 30, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, October 12, 2015TEAS STATEMENT OF USE RECEIVED
Monday, October 12, 2015TEAS REQUEST TO DIVIDE RECEIVED
Monday, October 12, 2015DIVISIONAL REQUEST RECEIVED
Monday, October 12, 2015USE AMENDMENT FILED
Monday, November 2, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, November 4, 2015DIVISIONAL PROCESSING COMPLETE
Tuesday, November 17, 2015NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, November 4, 2015STATEMENT OF USE PROCESSING COMPLETE
Thursday, November 5, 2015NOTICE OF PSEUDO MARK E-MAILED
Saturday, November 14, 2015ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, December 22, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, October 11, 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 11, 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 8, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 22, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, November 22, 2021TEAS SECTION 8 & 15 RECEIVED
Monday, May 16, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, May 16, 2022REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, May 16, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, June 8, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, June 8, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 8, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, December 22, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Related Keywords

biosciences imago development research pharmaceutical